BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2310661)

  • 1. Comparative haemodynamic effects of intravenous nisoldipine and hydralazine in congestive heart failure.
    Haitas B; Meyer TE; Angel ME; Reef E
    Br J Clin Pharmacol; 1990 Mar; 29(3):366-8. PubMed ID: 2310661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease.
    Donaldson KM; Dawkins KD; Waller DG
    Br J Clin Pharmacol; 1993 Oct; 36(4):315-21. PubMed ID: 12959309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of nisoldipine by oral route.
    Razzolini R; Boffa GM; Calvanese A; Isabella G; Ramondo A; Chioin R
    Pharmacol Res; 1991 Oct; 24(3):257-62. PubMed ID: 1956870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
    Mehta J; Iacona M; Pepine CJ; Conti CR
    Br Heart J; 1979 Dec; 42(6):664-70. PubMed ID: 534583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable hemodynamic response to oral hydralazine in patients with refractory congestive heart failure.
    LeJemtel TH; Elkayam U; Ribner HS; Hellman C; Strom J; Frishman W; Strobeck J; Sonnenblick EH
    Eur Heart J; 1980 Jun; 1(3):157-63. PubMed ID: 7026250
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
    Pierpont GL; Cohn JN; Franciosa JA
    Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute haemodynamic and neurohumoral effects of intravenous nisoldipine in patients with severe congestive heart failure.
    Erlemeier HH; Kupper W; Bleifeld W
    Eur J Clin Pharmacol; 1990; 38(1):11-5. PubMed ID: 2184040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-parenteral combined afterload and preload reduction therapy in congestive heart failure.
    Mehta J; Pepine CJ; Conti CR
    Clin Cardiol; 1978 Aug; 1(2):68-73. PubMed ID: 116791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the second-generation calcium channel blocker nisoldipine on left ventricular contractility in cardiac failure.
    Lewis BS; Shefer A; Merdler A; Flugelman MY; Hardoff R; Halon DA
    Am Heart J; 1988 Jun; 115(6):1238-44. PubMed ID: 3376841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure.
    Hamilton SF; Houle LM; Thadani U
    Heart Dis; 1999; 1(5):279-88. PubMed ID: 11720635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilators as first-line therapy for congestive heart failure: a comparative hemodynamic study of hydralazine, digoxin, and their combination.
    Ribner HS; Zucker MJ; Stasior C; Talentowski D; Stadnicki R; Lesch M
    Am Heart J; 1987 Jul; 114(1 Pt 1):91-6. PubMed ID: 3604877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
    Chatterjee K; Ports TA; Arnold S; Brundage B; Parmley W
    Br Heart J; 1979 Dec; 42(6):657-63. PubMed ID: 534582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of nisoldipine in chronic congestive heart failure.
    Vogt A; Kreuzer H
    Arzneimittelforschung; 1983; 33(6):877-9. PubMed ID: 6684444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous nisoldipine in severe congestive heart failure.
    Moe GW; Karlinsky SJ; Frankel D; Armstrong PW
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):160-6. PubMed ID: 2459547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydralazine in the management of left ventricular failure.
    Fitchett DH; Neto JA; Oakley CM; Goodwin JF
    Am J Cardiol; 1979 Aug; 44(2):303-9. PubMed ID: 463768
    [No Abstract]   [Full Text] [Related]  

  • 17. Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease.
    Fodor JG
    Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():873-9. PubMed ID: 9126676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acute effects of intravenous nisoldipine on left ventricular function within 24 h after acute myocardial infarction.
    Chin JC; van der Wall EE; Manger Cats V; van der Laarse A; Blokland JA; Pauwels EJ; Bruschke AV
    Eur Heart J; 1992 Dec; 13(12):1684-91. PubMed ID: 1289100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris.
    Jackson NC; Silke B; Verma SP; Reynolds G; Hafizullah M; Taylor SH
    Postgrad Med J; 1984; 60 Suppl 4():11-6. PubMed ID: 6527973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nisoldipine improves blood flow to skeletal muscles in conscious pigs with chronic heart failure.
    van der Giessen WJ; van Woerkens LJ; Saxena PR; Roelandt JR; Verdouw PD
    Eur Heart J; 1990 Jun; 11(6):552-9. PubMed ID: 2351164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.